Precision BioSciences, Inc.
DTIL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $68,696 | $48,727 | $25,098 | $115,529 |
| % Growth | 41% | 94.1% | -78.3% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $68,696 | $48,727 | $25,098 | $115,529 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $59,559 | $53,375 | $46,122 | $115,238 |
| G&A Expenses | $35,299 | $39,088 | $41,284 | $39,667 |
| SG&A Expenses | $35,299 | $39,088 | $41,284 | $39,667 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $94,858 | $92,463 | $87,406 | $154,905 |
| Operating Income | -$26,162 | -$43,736 | -$62,308 | -$39,376 |
| % Margin | -38.1% | -89.8% | -248.3% | -34.1% |
| Other Income/Exp. Net | $33,329 | $1,209 | -$10,601 | $8,774 |
| Pre-Tax Income | $7,167 | -$42,527 | -$72,909 | -$30,602 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $7,167 | -$61,319 | -$111,637 | -$30,602 |
| % Margin | 10.4% | -125.8% | -444.8% | -26.5% |
| EPS | 1.05 | -15.96 | -38.1 | -15.6 |
| % Growth | 106.6% | 58.1% | -144.2% | – |
| EPS Diluted | 1.04 | -15.96 | -38.1 | -15.6 |
| Weighted Avg Shares Out | 6,833 | 3,841 | 2,930 | 1,956 |
| Weighted Avg Shares Out Dil | 6,884 | 3,841 | 2,930 | 1,956 |
| Supplemental Information | – | – | – | – |
| Interest Income | $6,763 | $7,686 | $3,473 | $208 |
| Interest Expense | $1,782 | $2,230 | $1,111 | $132 |
| Depreciation & Amortization | $4,577 | $8,255 | $9,004 | $10,197 |
| EBITDA | $13,526 | -$32,042 | -$62,794 | -$20,273 |
| % Margin | 19.7% | -65.8% | -250.2% | -17.5% |